AUCKLAND, New Zealand--(BUSINESS WIRE)--Jul 23, 2026-- Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurbs effectiveness in weight loss and muscle preservation
As a 503A designated pharmacy, adhering to USP standards is fundamental to Hallandales operations, and the pharmacy states it goes beyond compliance through ongoing product testing, scientific research, validated processes, regular facility maintenance, and comprehensive personnel training
A heavier person distributes the same dose across more tissue, resulting in lower peak levels
Despite the ongoing discussion of cancer risks, that hasn't stopped social media from spreading misinformation about the peptide
The intestines are suddenly exposed to higher GLP-1 levels, which increase fluid secretion and speed up bowel contractions